American Health Packaging announces nationwide recall of Ibuprofen and Oxcarbazepine Tablets
American Health Packaging has recalled one lot of 600-mg ibuprofen tablets in a hospital unit dose presentation and one lot of oxcarbazepine tablets, 300 mg. This voluntary recall is the result of mislabeled inner unit dose blister packaging, which could result in patients receiving ibuprofen and missing their scheduled dose of oxcarbazepine. These hospital unit dose products were distributed nationwide from June 20, 2014.The recall was initiated after receiving one customer complaint that resulted in the investigation. There have not been any reports of adverse events attributable to the mislabeled drug.However, it is known that inadvertent consumption of ibuprofen in some patients can cause problems and that an epilepsy patient missing a dose of oxcarbazepine could increase the chances of having a seizure.
Ibuprofen tablets are used for the relief of mild to moderate pain; for relief of the signs and symptoms of rheumatoid arthritis and osteoarthritis; and treatment of primary dysmenorrhea. Oxcarbazepine is used for treating certain types of seizures in patients with epilepsy. American Health Packaging initiated the voluntary product recall on July 1, 2014 as a safety precaution, and will continue to closely monitor for reports of adverse drug reactions and product complaints.